Health trends in England: A new summary report to introduce Fingertips public health data to a broader audience.

How do you convert data collected at Drug and Alcohol Treatment Team (DAT) level into indicators for local authorities?

The metadata for the indicator which has been converted from DAT level to local authority level describes in detail how this is done. This applies to indicator 90883 (percentage of people who inject drugs, aged 15 to 64 years).

Will you publish data for district councils?

Due to the nature of the indicators, and the inherently small numbers involved (particularly for NAFLD and the hepatitidies), we are unable to produce reliable, robust analyses to populate the indicators at the lower tier (district) level.

How can I compare my area to other local authorities?

If you want to compare your local authorities to others in the same region, do this:

  1. Go to the profile.
  2. Go to the 'Data view' dropdown menu.
  3. Select ‘Overview’.

Other comparators may be added in future.

If you have any specific requirements, email >

How are indicators selected for the liver disease profile?

The indicators are developed in collaboration with expert input from stakeholders, epidemiologists, clinicians and professionals in alcohol, drugs, hepatitis and obesity.

The aim is to provide a comprehensive means of assessing the suitability of each candidate indicator. These were used to assess the final set of indicators including those suggested in response to the consultation exercises.

What are official statistics?

Updates to the public health outcomes framework data tool are published as official statistics. They are produced in accordance with best practice set out in the code of practice for official statistics to ensure that they are fit for purpose, methodologically sound, politically independent and produced in a transparent way.

Why are some indicators presented as 'higher' or 'lower' than the benchmark and shaded blue, instead of 'better' or 'worse' and shaded red, amber or green?

Indicators that are shaded blue rather than red, amber or green are presented in this way because it’s not possible or appropriate to apply the explicit value judgement inherent in the 'better' or 'worse' system. For example, the 'Percentage of people who inject drugs indicator' is an artefact of the population demographics (a measure of population at risk) of a particular local authority; this means, it’s not a measure of performance as is implied by the 'better' or 'worse' system.

Indicators that are shaded white do not have confidence intervals associated with them by which to compare against the benchmark value. Therefore, it’s not possible to determine whether the local value is statistically significantly higher or lower than the benchmark.

How do you determine the colour of areas for particular indicators in the tool?

The way that the colour is assigned is based on statistically significant differences from the England value. This is determined within the liver disease profile tool by:

  • using the England value
  • seeing whether this lies within the confidence interval of the local authority in question

Who is responsible for collating and publishing liver disease profile data?

This is responsibility of the Public Health Analysis Unit of the Office for Health Improvement and Disparities (OHID).

What are the sources of data for liver disease profiles indicators?

Indicators in the liver disease profiles have been based on existing data sources wherever possible. The data source for each indicator is set out within the definitions tab.

Can I re-use the data and charts in my own work?

You can use and reuse the data and charts from the liver disease profile tool free of charge in any format or medium under the terms of the open government licence.

You have to state that the information is from the 'Office for Health Improvement and Disparities (OHID) liver disease profile' in your document.

You cannot include any logo in your document.

How can I influence what indicators are included in the liver disease profile in future?

For enquiries or feedback relating to the liver disease profile, email